← Evidence map

ArticleCancers2025

Survival Outcomes of Luminal Metastatic Breast Cancer Patients According to Changes in Molecular Subtype at Re-Biopsy: Insights from the GIM-13-AMBRA Study.

Marina Elena Cazzaniga et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Survival Outcomes of Luminal Metastatic Breast Cancer Patients According to Changes in Molecular Subtype at Re-Biopsy: Insights from the GIM-13-AMBRA Study. | OpenQuestion